01/13/2025
7:49 AM | 10x Genomics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
7:29 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:53 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:52 PM | 10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
3:56 PM | 10x Genomics (Subject)
Hindson Benjamin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2024
3:38 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
3:43 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/08/2024
1:46 PM | 10x Genomics (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
| Form SC 13G | |
11/05/2024
5:07 AM | 10x Genomics (Subject)
Sumitomo Mitsui Trust Group, Inc. (Filed by)
| Form SC 13G | |
10/09/2024
3:07 PM | 10x Genomics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
1:14 PM | 10x Genomics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
09/04/2024
4:34 PM | 10x Genomics (Issuer)
Teichmann Sarah A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
4:03 PM | 10x Genomics (Issuer)
10x Genomics (Issuer)
McAnear Justin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
4:04 PM | 10x Genomics (Issuer)
10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
4:05 PM | 10x Genomics (Issuer)
10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:39 PM | 10x Genomics (Subject)
Hindson Benjamin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024
7:42 PM | 10x Genomics (Subject)
McAnear Justin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024
7:45 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
10:16 AM | 10x Genomics (Subject)
ARK Investment Management LLC (Filed by)
| Form SC 13G | |
07/19/2024
3:42 PM | 10x Genomics (Issuer)
Teichmann Sarah A. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/26/2024
3:48 PM | 10x Genomics (Issuer)
MATEO ALAN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/13/2024
3:08 PM | 10x Genomics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
8:55 AM | 10x Genomics (Subject)
BAILLIE GIFFORD & CO (Filed by)
| Form SC 13G/A | |
05/23/2024
6:52 PM | 10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:53 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:54 PM | 10x Genomics (Issuer)
McAnear Justin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:23 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2024
3:27 PM | 10x Genomics (Subject)
Hindson Benjamin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2024
3:17 PM | 10x Genomics (Subject)
McAnear Justin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/12/2024
3:23 PM | 10x Genomics (Filer)
| Form PRE 14A | |
03/25/2024
4:15 PM | 10x Genomics (Issuer)
McAnear Justin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
4:16 PM | 10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
4:17 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
6:02 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:40 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024
6:19 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024
5:59 PM | 10x Genomics (Subject)
Hindson Benjamin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024
6:06 PM | 10x Genomics (Subject)
McAnear Justin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
3:20 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:33 PM | 10x Genomics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/09/2024
7:35 AM | 10x Genomics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
|
01/31/2024
1:08 PM | 10x Genomics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/29/2024
10:43 AM | 10x Genomics (Subject)
BAILLIE GIFFORD & CO (Filed by)
| Form SC 13G/A | |
01/18/2024
3:49 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
5:08 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free TXG Stock Alerts